Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation

Vitae Pharmaceuticals, Inc (VTAE) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/25/2016 4 Gregg Richard (Chief Science Officer) has filed a Form 4 on Vitae Pharmaceuticals, Inc
10/25/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
10/25/2016 4 LEONARD JOHN M. (Director) has filed a Form 4 on Vitae Pharmaceuticals, Inc
10/25/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
10/25/2016 4 Sable Carole (Chief Medical Officer) has filed a Form 4 on Vitae Pharmaceuticals, Inc
10/25/2016 4 Hatfield Jeffrey S. (CEO) has filed a Form 4 on Vitae Pharmaceuticals, Inc
10/25/2016 4 HAYDEN DONALD J JR (Director) has filed a Form 4 on Vitae Pharmaceuticals, Inc
10/25/2016 4 JUNIUS DANIEL M (Director) has filed a Form 4 on Vitae Pharmaceuticals, Inc
Txns: Disposed/sold 20,000 options to buy @ $11.37, valued at $227.4k
10/25/2016 4 Bernstein Karen (Director) has filed a Form 4 on Vitae Pharmaceuticals, Inc
10/25/2016 4 Fratamico Arthur (Chief Business Officer) has filed a Form 4 on Vitae Pharmaceuticals, Inc
10/25/2016 4 SANTINI GINO (Director) has filed a Form 4 on Vitae Pharmaceuticals, Inc
Txns: Disposed/sold 17,000 options to buy @ $8, valued at $136k
Disposed/sold 10,000 options to buy @ $12.43, valued at $124.3k
Disposed/sold 10,000 options to buy @ $9.62, valued at $96.2k
10/25/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
10/25/2016 4 Applebaum Scott (General Counsel) has filed a Form 4 on Vitae Pharmaceuticals, Inc
10/21/2016 4 Gregg Richard (Chief Science Officer) has filed a Form 4 on Vitae Pharmaceuticals, Inc
09/16/2016 4 Hatfield Jeffrey S. (CEO) has filed a Form 4 on Vitae Pharmaceuticals, Inc
09/16/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
08/17/2016 4 Fratamico Arthur (Chief Business Officer) has filed a Form 4 on Vitae Pharmaceuticals, Inc
08/17/2016 4 Gregg Richard (Chief Science Officer) has filed a Form 4 on Vitae Pharmaceuticals, Inc
08/17/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
08/17/2016 4 Hatfield Jeffrey S. (CEO) has filed a Form 4 on Vitae Pharmaceuticals, Inc
08/12/2016 4 Applebaum Scott (General Counsel) has filed a Form 4 on Vitae Pharmaceuticals, Inc
07/27/2016 4 JUNIUS DANIEL M (Director) has filed a Form 4 on Vitae Pharmaceuticals, Inc
Txns: Granted 20,000 options to buy @ $11.37, valued at $227.4k
07/27/2016 3 JUNIUS DANIEL M (Director) has filed a Form 3 on Vitae Pharmaceuticals, Inc
06/08/2016 4 Sable Carole (Chief Medical Officer) has filed a Form 4 on Vitae Pharmaceuticals, Inc
Txns: Granted 150,000 options to buy @ $10.51, valued at $1.6M
06/08/2016 3 Sable Carole (Chief Medical Officer) has filed a Form 3 on Vitae Pharmaceuticals, Inc
05/27/2016 4 Gunderson Robert V JR (Director) has filed a Form 4 on Vitae Pharmaceuticals, Inc
Txns: Granted 10,000 options to buy @ $9.62, valued at $96.2k
05/27/2016 4 SANTINI GINO (Director) has filed a Form 4 on Vitae Pharmaceuticals, Inc
Txns: Granted 10,000 options to buy @ $9.62, valued at $96.2k
05/27/2016 4 Bernstein Karen (Director) has filed a Form 4 on Vitae Pharmaceuticals, Inc
Txns: Granted 10,000 options to buy @ $9.62, valued at $96.2k
05/27/2016 4 ROBERTS BRYAN E (Director) has filed a Form 4 on Vitae Pharmaceuticals, Inc
Txns: Granted 10,000 options to buy @ $9.62, valued at $96.2k
05/27/2016 4 HAYDEN DONALD J JR (Director) has filed a Form 4 on Vitae Pharmaceuticals, Inc
Txns: Granted 10,000 options to buy @ $9.62, valued at $96.2k
05/27/2016 4 Rowland Charles A Jr (Director) has filed a Form 4 on Vitae Pharmaceuticals, Inc
Txns: Granted 10,000 options to buy @ $9.62, valued at $96.2k
05/27/2016 4 LEONARD JOHN M. (Director) has filed a Form 4 on Vitae Pharmaceuticals, Inc
Txns: Granted 10,000 options to buy @ $9.62, valued at $96.2k
03/28/2016 3 Form 3 - Initial statement of beneficial ownership of securities
03/21/2016 4 HAYDEN DONALD J JR (Director) has filed a Form 4 on Vitae Pharmaceuticals, Inc
Txns: Sold 16,130 shares @ $7.42, valued at $119.7k
Exercised 1,935 options to buy @ $3.45, valued at $6.7k
Exercised 14,195 options to buy @ $3.45, valued at $49k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy